Testing a device that stimulates the spleen in rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial studies whether splenic stimulation (using a medical device to stimulate the spleen) is safe for people with active rheumatoid arthritis. It may help some patients who have not improved enough after at least two other advanced arthritis medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have rheumatoid arthritis that started in adulthood and has lasted at least 6 months
- You are 22 to 75 years old, and your rheumatoid arthritis is currently active
- Your symptoms have not improved enough after at least 2 biologic medicines and/or JAK inhibitors
- If you recently used biologic medicines or JAK inhibitors, enough time has passed for a proper washout
- You do not have any ongoing infections (like tuberculosis, HIV, hepatitis B/C) and you can take study procedures safely
- You must be able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment that stimulates the spleen to help calm symptoms of active rheumatoid arthritis (RA). It’s mainly for people whose RA has not improved enough after several newer arthritis medicines.
This trial tests whether ultrasound waves applied to the spleen can reduce inflammation in adults with rheumatoid arthritis. It is for people with moderate to severe disease who have not tried many biologic medications.
This trial tests a new medication (BMS-986454) for people with rheumatoid arthritis who haven't responded well enough to methotrexate. It aims to see if the drug is safe and how it works in the body.
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
This trial tests an experimental drug for people with rheumatoid arthritis who have not had success with other treatments. It aims to see if the drug can help reduce joint pain and swelling.
This trial tests if a device that uses ultrasound waves, used at home, can help treat rheumatoid arthritis (RA). It is for people with moderate to severe RA who still have symptoms despite taking standard medications.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.